- Treatment of ANCA associated vasculitis2008 | First Faculty of Medicine
- Exposure to silicon and ANCA-associated vasculitidesPublication without faculty affiliation
- Alemtuzumab by refracting ANCA-associated vasculiltis2012 | First Faculty of Medicine
- Current treatment of ANCA - associated renal vasculitis2008 | First Faculty of Medicine
- News in the treatment of ANCA-associated vasculitides2013 | First Faculty of Medicine
- New Insights in the pathogenic role of ANCA (Anti-neutrophil cytoplasmic autoantibodies)2008 | First Faculty of Medicine
- Pathophysiology of ANCA-associated vasculitis2020 | First Faculty of Medicine
- ANCA -associated vasculitides and their treatment2009 | First Faculty of Medicine
- Granulomatosis with polyangiitis (Wegener's granulomatosis)2017 | First Faculty of Medicine
- Exposure to Silica and Risk of ANCA-Associated Vasculitis2006 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Complement Inhibition in ANCA-Associated Vasculitis2022 | First Faculty of Medicine
- Pitfalls of diagnosis of ANCA-associated vasculitis - case report2020 | First Faculty of Medicine, Central Library of Charles University
- Genetically distinct subsets within ANCA-associated vasculitis2012 | First Faculty of Medicine
- T cells in the pathogenesis of ANCA-associated vasculitis: current knowledge2008 | First Faculty of Medicine
- Diabetes insipidus caused by ANCA associated vasculitis2022 | First Faculty of Medicine
- Avacopan in the treatment of ANCA-associated vasculitis2018 | First Faculty of Medicine
- Clinical Factors and Adverse Kidney Outcomes in Children With ANCA-Associated Glomerulonephritis2023 | Second Faculty of Medicine
- Silica and Asbestos Exposure in ANCA-Associated Vasculitis with Pulmonary Involvement2005 | Second Faculty of Medicine
- Lupus nephritis and ANCA-associated vasculitis: towards precision medicine?2021 | First Faculty of Medicine
- Outcome of thirty patients with ANCA - associated renal vasculitis admitted to the intensive care unit2008 | First Faculty of Medicine
- Treatment of refractory ANCA-associated vasculitis with rituximab. Commentary on: Arthritis and Reheumatism 60,2009,s.2156-21682009 | First Faculty of Medicine
- Efficiency of rituximab in ANCA-associated vasulitis in comparison with standard induction and maintanance treatment2013 | First Faculty of Medicine
- Modern therapy of ANCA associated vasculitides2013 | First Faculty of Medicine
- Limitations of standard immunosuppressive treatment in ANCA-associated vasculitis and lupus nephritis2014 | First Faculty of Medicine
- Rituximab for treatment of severe renal disease in ANCA associated vasculitis2016 | First Faculty of Medicine
- Antineutrophil cytoplasmic antibodies (ANCA), their diagnostic importance in children and adults1997 | Second Faculty of Medicine
- Significance of serum antibodies ANCA, ASCA, ABBA in idiopatic intestinal inflammation2007 | Publication without faculty affiliation
- Significance of serum antibodies ANCA, ASCA, ABBA in idiopatic intestinal inflammation +12007 | Faculty of Medicine in Hradec Králové
- Significance of serum antibodies ANCA, ASCA, ABBA in idiopatic intestinal inflammation2007 | First Faculty of Medicine